Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01IVE
|
||||
| Former ID |
DNC002402
|
||||
| Drug Name |
Lobeline
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Substance dependence [ICD10:F10-F19] | Phase 2 | [532434] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H27NO2
|
||||
| Canonical SMILES |
CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O
|
||||
| InChI |
1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21+/m0/s1
|
||||
| InChIKey |
MXYUKLILVYORSK-PWRODBHTSA-N
|
||||
| CAS Number |
CAS 90-69-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Synaptic vesicle amine transporter | Target Info | Inhibitor | [531251] | |
| PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
| 5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathway | |||||
| CCKR signaling map ST | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.